Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia

This study has been completed.
Epidemiological and Clinical Research Information Network
Information provided by:
Kanto CML Study Group Identifier:
First received: March 18, 2009
Last updated: September 14, 2015
Last verified: December 2010